by HBOT News | Feb 29, 2020 | Clinical Trials, HBOT Research, Ilioinguinal Nerve Block
Regional anesthesia is a popular anesthetic method in patients who will undergo an inguinal
hernia operation. Researchers known that pain in the operating area is a complaint that
impairs the quality of life for patients in the long term after the operation. In addition to
regional anesthesia, has planned to investigate the effects of applying another drug near the
surgery area on pain that may develop in the long term.
by HBOT News | Feb 3, 2020 | Mental Health News
Justin Beiber has a hyperbaric oxygen chamber in his home and one in his studio. He uses these chambers to help manage his stress and anxiety. There are many different types of HBOT chambers; but for Beiber, his chambers are pod-like, resembling a big blue bag....
by HBOT News | Oct 2, 2019 | Clinical Trials, HBOT Research, Shoulder Pain
Laparoscopic cholecystectomy (LC) has been routinely performed under general anesthesia
despite the several disadvantages of general anesthesia compared to regional anesthesia.
There are multiple reports that have been published regarding the feasibility of spinal
anesthesia for LC associated with many problems such as referred shoulder pain secondary to
intra-abdominal pneumoperitoneum; patient anxiety, pain, and discomfort; and inadequate
sedation.The aim of our study is to prospectively observe the feasibility of using
intravenous dexmedetomidine to abolish patient discomfort and shoulder pain, thus making the
patient more comfortable without causing excessive sedation and respiratory depression.
by HBOT News | Sep 1, 2019 | Clinical Trials, HBOT Research, Maternal Hypotension After Spinal Anesthesia
Doses of intrathecal bupivacaine based on patients either height or height and weight has
shown to lower the risk of maternal hypotension with similar quality of anesthesia compared
to conventional doses.
In clinical practice there is a tendency of reducing the dose of bupivacaine as either low
fixed dose or using the doses based on either height and weight or height (0.06mg/cm) alone
in parturient with short stature. However, there is lack of evidence regarding the
appropriate dose required in this group of patients. Therefore, our aim is to compare the
height versus height and weight based intrathecal bupivacaine dose for elective caesarean on
maternal haemodynamics in short stature patients.
by HBOT News | Apr 24, 2019 | Clinical Trials, HBOT Research, Nausea
The aim of this study is to evaluate the prophylactic use of low dose atropine and comparing
it to metoclopramide for reducing intraoperative nausea and vomiting during cesarean section
under spinal anesthesia
